{"id":"https://openalex.org/W2593847736","doi":"https://doi.org/10.1182/blood.v126.23.2810.2810","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Simtuzumab in Adult Subjects with Primary, Post Polycythemia Vera (PV) or Post Essential Thrombocythemia (ET) Myelofibrosis","display_name":"A Phase 2 Study to Evaluate the Efficacy and Safety of Simtuzumab in Adult Subjects with Primary, Post Polycythemia Vera (PV) or Post Essential Thrombocythemia (ET) Myelofibrosis","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2593847736","doi":"https://doi.org/10.1182/blood.v126.23.2810.2810","mag":"2593847736"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2810.2810","doi":"https://doi.org/10.1182/blood.v126.23.2810.2810","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2810.2810","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085521139","display_name":"Sr\u0111an Verstov\u0161ek","orcid":"https://orcid.org/0000-0002-6912-8569","observed_orcids":["https://orcid.org/0000-0002-6912-8569"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srdan Verstovsek","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Vanderbilt University School of Medicine, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002632381","display_name":"Stephen T. Oh","orcid":"https://orcid.org/0000-0002-8564-5400","observed_orcids":["https://orcid.org/0000-0002-8564-5400","https://orcid.org/0000-0002-7330-0106"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Oh","raw_affiliation_strings":["Division of Hematology, Washington University School of Medicine, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Washington University School of Medicine, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112080484","display_name":"Hua Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hua Dong","raw_affiliation_strings":["Gilead Sciences, Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108665321","display_name":"Dung Luong Thai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dung Thai","raw_affiliation_strings":["Gilead Sciences, Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065621786","display_name":"Jason R. Gotlib","orcid":"https://orcid.org/0000-0001-8253-6156","observed_orcids":["https://orcid.org/0000-0001-8253-6156"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Gotlib","raw_affiliation_strings":["School of Medicine/ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine/ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5108665321","https://openalex.org/A5112080484"],"corresponding_institution_ids":["https://openalex.org/I4210140816"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.5241,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.67938425,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"126","issue":"23","first_page":"2810","last_page":"2810"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/post-polycythemia-vera-myelofibrosis","display_name":"post-polycythemia vera myelofibrosis","score":0.9110000133514404},{"id":"https://openalex.org/keywords/post-essential-thrombocythemia-myelofibrosis","display_name":"post-essential thrombocythemia myelofibrosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.8270000219345093},{"id":"https://openalex.org/keywords/bone-marrow-fibrosis","display_name":"bone marrow fibrosis","score":0.8299999833106995},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.6359999775886536},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.47999998927116394},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.8730000257492065},{"id":"https://openalex.org/keywords/fibroblast-activation","display_name":"fibroblast activation","score":0.45399999618530273},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.8541766405105591},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7414806485176086},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.602474570274353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.555378258228302},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.5249148011207581},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4941568672657013},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.4862743616104126},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4272814393043518},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.4266117811203003},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.4112669825553894},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.3976133465766907},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.34146198630332947},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2495477795600891},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.22945493459701538}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2810.2810","doi":"https://doi.org/10.1182/blood.v126.23.2810.2810","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2810.2810","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2590741349","https://openalex.org/W4389122341","https://openalex.org/W2555617731","https://openalex.org/W2560640434","https://openalex.org/W2896860602","https://openalex.org/W2980541530","https://openalex.org/W4405044957","https://openalex.org/W2408729117","https://openalex.org/W2980830065","https://openalex.org/W4417007140"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Simtuzumab":[2],"(SIM)":[3],"is":[4,28,418,446],"a":[5,138,156,301,344],"humanized":[6],"monoclonal":[7],"antibody":[8],"that":[9,20],"inhibits":[10],"lysyl":[11],"oxidase-like":[12],"molecule":[13],"2":[14,171,287,330],"(LOXL2),":[15],"an":[16,46,357,470,483,505,516,527,567,578],"extracellular":[17],"matrix":[18],"enzyme":[19],"catalyzes":[21],"the":[22,50,83,217,230,281,295,324,338],"covalent":[23],"cross-linking":[24],"of":[25,39,52,85,125,132,148,362,436,455,473,486,508,519,530,570,581],"collagen":[26],"and":[27,71,90,103,118,196,210,237,242,249,255,269,286,329,404,442,448,459],"widely":[29],"expressed":[30],"across":[31],"many":[32],"fibrotic":[33],"diseases.":[34],"In":[35,55,274,313,356],"pre-clinical":[36],"models,":[37],"inhibition":[38],"LOXL2":[40],"blocks":[41],"fibroblast":[42],"activation,":[43],"which":[44],"plays":[45],"important":[47],"role":[48],"in":[49,62,97,140,155,239,280,294,303,323,337,346,366,379,384,406,414,428,439,444,457],"development":[51],"organ":[53],"fibrosis.":[54],"Phase":[56,77],"1":[57,316],"studies,":[58],"SIM":[59,86,166,187,259,263,282,296,325,339,371,410,456],"was":[60,106,130,208,373],"well-tolerated":[61],"patients":[63,441],"(pts)":[64],"with":[65,92,99,150,180,376,399,416,430],"advanced":[66],"solid":[67],"tumors,":[68],"liver":[69,460],"fibrosis,":[70],"idiopathic":[72],"pulmonary":[73],"fibrosis":[74,143,206,306,349,369,427,438,461],"(IPF).":[75],"A":[76],"2,":[78,183,315],"open-label":[79],"study":[80],"to":[81,159,190,310,353],"determine":[82],"efficacy":[84],"alone":[87,412],"(Stage":[88,95,175,182],"1)":[89],"combined":[91,179],"ruxolitinib":[93],"(rux)":[94],"2)":[96],"pts":[98,110,252,429],"primary":[100,128],"myelofibrosis":[101],"(PMF)":[102],"post-ET/PV":[104],"MF":[105],"initiated.":[107],"Methods:":[108],"Eligible":[109],"had":[111],"intermediate-1,":[112],"intermediate-2,":[113],"or":[114,163,178,382,387,413,475,488,510,521,532,572,583],"high":[115],"risk":[116],"disease":[117],"Eastern":[119],"Cooperative":[120],"Oncology":[121],"Group":[122],"performance":[123],"status":[124],"<2.":[126],"The":[127,390,432],"endpoint":[129],"rate":[131],"clinical":[133],"response":[134],"as":[135,173],"defined":[136],"by":[137,167],"reduction":[139,302,345,435],"bone":[141,304,347,367,425],"marrow":[142,194,205,305,348,368,426,437],"score":[144,307,350,386],"following":[145],"24":[146,191],"weeks":[147,172],"treatment":[149,372,411],"SIM.":[151],"Patients":[152,185],"were":[153,198,227,244,253,395],"randomized":[154,254],"1:1":[157],"ratio":[158],"receive":[160],"200":[161,265,283,326],"mg":[162,165,258,262,266,271,284,298],"700":[164,261,270,297,340],"intravenous":[168],"infusion":[169],"every":[170,201],"monotherapy":[174],"1,":[176,276],"n=24)":[177],"rux":[181,417],"n=30).":[184],"received":[186],"for":[188,434],"up":[189],"weeks.":[192],"Bone":[193,204,222],"biopsies":[195],"aspirates":[197],"performed":[199,209],"approximately":[200],"3":[202],"months.":[203],"scoring":[207],"quantified":[211],"at":[212],"local":[213],"investigator":[214],"sites":[215],"using":[216,229],"European":[218],"Consensus":[219],"on":[220,469,482,504,515,526,566,577],"Grading":[221],"Marrow":[223],"Fibrosis.":[224],"Myelofibrosis":[225],"symptoms":[226,403],"evaluated":[228],"Myeloproliferative":[231],"Neoplasm":[232],"Symptom":[233],"Assessment":[234],"Form":[235],"(MPN-SAF)":[236],"changes":[238],"hematologic":[240,380],"parameters":[241,381],"splenomegaly":[243],"assessed.":[245],"Results:":[246],"Between":[247],"7/14/11":[248],"9/22/14,":[250],"54":[251],"treated":[256],"(200":[257],"[n=12],":[260,264],"SIM/rux":[267,272],"[n=15],":[268],"[n=15]).":[273],"Stage":[275,314],"0":[277],"subjects":[278,288,331,363],"(0%)":[279],"group":[285,299,328,342],"(16.7%;":[289],"90%":[290,319,333],"CI":[291,320,334],"3.0%,":[292],"43.8%)":[293],"showed":[300,343,364],"from":[308,351],"Baseline":[309,352],"Week":[311,354],"24.":[312,355],"subject":[317],"(6.7%;":[318],"0.3%,":[321],"27.9%)":[322],"mg/rux":[327,341],"(13.3%,":[332],"2.4%,":[335],"36.3%)":[336],"exploratory":[358],"analysis,":[359],"similar":[360],"numbers":[361],"increases":[365],"scores.":[370],"not":[374,422],"associated":[375,398],"meaningful":[377],"improvements":[378],"reductions":[383,405],"MPN-SAF":[385],"spleen":[388],"size.":[389],"most":[391],"frequent":[392],"adverse":[393],"events":[394],"those":[396],"commonly":[397],"MF,":[400],"including":[401],"constitutional":[402],"hematological":[407],"parameters.":[408],"Conclusions:":[409],"combination":[415],"safe":[419],"but":[420],"does":[421],"reliably":[423],"reduce":[424],"MF.":[431],"reason":[433],"some":[440],"increase":[443],"others":[445],"unclear":[447],"may":[449],"be":[450],"sampling":[451],"variability.":[452],"Clinical":[453],"studies":[454],"IPF":[458],"are":[462],"ongoing.":[463],"Disclosures":[464],"Savona:":[465],"Karyopharm:":[466],"Consultancy,":[467,588],"Membership":[468,481,503,514,525,565,576],"entity's":[471,484,506,517,528,568,579],"Board":[472,485,507,518,529,569,580],"Directors":[474,487,509,520,531,571,582],"advisory":[476,489,511,522,533,573,584],"committees,":[477,490],"Research":[478,491,495,500,537,541,548,551,554,558,561],"Funding;":[479,492,496,501,538,542,549,552,555,559],"Incyte:":[480,575],"TG":[493],"Therapeutics:":[494],"Astex":[497],"Pharmaceuticals,":[498],"Inc:":[499],"Celgene:":[502],"committees;":[512,523,574],"Gilead:":[513,560],"Novartis:":[524],"committees.":[534,585],"Mesa:Incyte":[535],"Corporation:":[536,545],"CTI":[539],"Biopharma:":[540,564],"Novartis":[543],"Pharmaceuticals":[544],"Consultancy;":[546],"Pfizer:":[547],"Promedior:":[550],"Genentech:":[553],"NS":[556],"Pharma:":[557],"Funding.":[562],"Oh:CTI":[563],"Dong:Gilead":[586],"Sciences:":[587,592],"Equity":[589,594],"Ownership.":[590,595],"Thai:Gilead":[591],"Employment,":[593],"Gotlib:Allakos,":[596],"Inc.:":[597],"Consultancy.":[598]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-16T00:00:00"}